Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...
– ETX301 nominated as a development candidate for post-amputation neuroma pain, with a planned IND submission in 2027 – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc.
How sensory systems rapidly adapt to changing stimulus statistics remains unclear. Here the authors show that gain adaptation in recurrent networks can implement fast efficient coding, unifying prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results